From February 22, 2024 to March 31, 2024, the company has repurchased 272,900 shares, representing 0.41% for CNY 8.99 million. With this, the company has completed the repurchase of 272,900 shares, representing 0.41% for CNY 8.99 million under the buyback announced on February 23, 2024.
Medprin Regenerative Medical Technologies Co., Ltd.
Equities
301033
CNE100004NB8
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.74 CNY | +4.17% |
|
+5.57% | -6.43% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.43% | 370M | |
+12.37% | 128B | |
-9.54% | 10.75B | |
-17.40% | 7.19B | |
+47.72% | 6.41B | |
-31.81% | 4.12B | |
+8.15% | 3.43B | |
-20.83% | 2.43B | |
-18.87% | 1.9B | |
-25.13% | 1.66B |
- Stock Market
- Equities
- 301033 Stock
- News Medprin Regenerative Medical Technologies Co., Ltd.
- Tranche Update on Medprin Regenerative Medical Technologies Co., Ltd.'s Equity Buyback Plan announced on February 23, 2024.